Vaxcyte

Vaxcyte PCVX Stock

$59.47   0.967741%
Add to favorites
Market Cap
$8.85B
LOW - HIGH [24H]
$58.23 - $60.20
VOLUME [24H]
$1.68M
P/E Ratio
0
Earnings per share
-$7.70
ISIN
US92243G1085
Price   Prediction

Vaxcyte Price Chart

Sorry, that's all we've gotfor now...

Vaxcyte PCVX Financial and Trading Overview

Vaxcyte stock price 59.47 USD
Previous Close 58.9 USD
Open 59.47 USD
Bid 42.51 USD x 200
Ask 75.13 USD x 200
Day's Range 58.23 - 60.2 USD
52 Week Range 30.81 - 65 USD
Volume 1.41M USD
Avg. Volume 1.28M USD
Market Cap 8.81B USD
Beta (5Y Monthly) 1.22
PE Ratio (TTM) N/A
EPS (TTM) -7.7 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 109 USD

PCVX Valuation Measures

Enterprise Value 7.39B USD
Trailing P/E N/A
Forward P/E -8.202695
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 3.1079378
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -6.436

Trading Information

Vaxcyte Stock Price History

Beta (5Y Monthly) 1.22
52-Week Change 83.08%
S&P500 52-Week Change 15.30%
52 Week High 65 USD
52 Week Low 30.81 USD
50-Day Moving Average 58.32 USD
200-Day Moving Average 54.23 USD

PCVX Share Statistics

Avg. Volume (3 month) 1.28M USD
Avg. Daily Volume (10-Days) 1.07M USD
Shares Outstanding 148.81M
Float 136.47M
Short Ratio 15.77
% Held by Insiders 0.49%
% Held by Institutions 113.42%
Shares Short 15.02M
Short % of Float 10.14%
Short % of Shares Outstanding 10.08%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.60%
Return on Equity (ttm) -36.51%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -1148780032 USD
Net Income Avi to Common (ttm) -1064260992 USD
Diluted EPS (ttm) -7.63
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.49B USD
Total Cash Per Share (mrq) 9.99 USD
Total Debt (mrq) 115.45M USD
Total Debt/Equity (mrq) 4.19 USD
Current Ratio (mrq) 5.724
Book Value Per Share (mrq) 19.048

Cash Flow Statement

Operating Cash Flow (ttm) -881233024 USD
Levered Free Cash Flow (ttm) -485755264 USD

Profile of Vaxcyte

Country United States
State CA
City San Carlos
Address 825 Industrial Road
ZIP 94070
Phone 650 837 0111
Website https://vaxcyte.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 507

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Q&A For Vaxcyte Stock

What is a current PCVX stock price?

Vaxcyte PCVX stock price today per share is 59.47 USD.

How to purchase Vaxcyte stock?

You can buy PCVX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Vaxcyte?

The stock symbol or ticker of Vaxcyte is PCVX.

Which industry does the Vaxcyte company belong to?

The Vaxcyte industry is Biotechnology.

How many shares does Vaxcyte have in circulation?

The max supply of Vaxcyte shares is 148.81M.

What is Vaxcyte Price to Earnings Ratio (PE Ratio)?

Vaxcyte PE Ratio is now.

What was Vaxcyte earnings per share over the trailing 12 months (TTM)?

Vaxcyte EPS is -7.7 USD over the trailing 12 months.

Which sector does the Vaxcyte company belong to?

The Vaxcyte sector is Healthcare.

Vaxcyte PCVX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 26333.04 USD
+0.96
5.66B USD 26283.11 USD 26431.22 USD 5.66B USD
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD
-1.26
3927.42 USD 4148.65 USD
us US Tech US 700 Small Cap Index NQUS700SC US 3079.71 USD
+0.6
3078.59 USD 3102.26 USD
us US Tech Global Select Market Com NQGS US 12940.54 USD
+0.98
12913.4 USD 12988.37 USD
us US Tech Biotechnology NBI US 6924.69 USD
+0.05
6924.47 USD 7006.06 USD
us US Tech Health Care IXHC US 1293.65 USD
+0.08
1293.64 USD 1310.12 USD
us US Tech US Smart Pharmaceuticals NQSSPH US 2146.67 USD
-0.06
2145.36 USD 2167.86 USD
$2.66T
Total marketcap
$51.68B
Total volume
BTC 58.21%     ETH 11.56%
Dominance
Select currency